Dren Bio, a San Carlos, Calif.-based cancer and autoimmune biotech, raised $350m in a round led by Juvia Group and Lightspeed Venture Partners. Mirae Asset Capital Life Science, General Catalyst, Cormorant Asset Management and OrbiMed participated. Go deeper
NeuroXess, a Chinese brain-computer interface startup, raised around $105m in Series B funding led by SDIC Juli, Shenzhen Capital Group, and Qinzhi Capital. Go deeper
